Insider · CIK 0001280154

OCAMPO CHRISTINE

Reports to the SEC for 4 companies · ALISO VIEJO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001280154

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-03-29	Urovant Sciences Ltd.D Disposition to Issuer	PAO; CAO/Urovant Sciences,Inc.	DDisposition to Issuer	−9,810 sh	—	—	0
2021-03-29	Urovant Sciences Ltd.D Disposition to Issuer	PAO; CAO/Urovant Sciences,Inc.	DDisposition to Issuer	−69K sh	—	—	0
2021-03-29	Urovant Sciences Ltd.Stock Option (Right to Buy)D Disposition to Issuer	PAO; CAO/Urovant Sciences,Inc.	DDisposition to Issuer	−134K sh	—	—	0
2021-03-29	Urovant Sciences Ltd.Stock Option (Right to Buy)D Disposition to Issuer	PAO; CAO/Urovant Sciences,Inc.	DDisposition to Issuer	−3,750 sh	—	—	0
2021-03-29	Urovant Sciences Ltd.Stock Option (Right to Buy)D Disposition to Issuer	PAO; CAO/Urovant Sciences,Inc.	DDisposition to Issuer	−70K sh	—	—	0
2020-05-01	Urovant Sciences Ltd.A Award	PAO; CAO/Urovant Sciences,Inc.	AAward	+44.3K sh	—	—	77,179
2020-01-07	Urovant Sciences Ltd.A Award	PAO; CAO/Urovant Sciences,Inc.	AAward	+32.8K sh	—	—	32,833
2019-01-06	Urovant Sciences Ltd.Stock Option (Right to Buy)A Award	PAO; CAO/Urovant Sciences,Inc.	AAward	+70K sh	—	—	70,000
2018-10-15	Urovant Sciences Ltd.Stock Option (Right to Buy)A Award	PAO; CAO/Urovant Sciences,Inc.	AAward	+3,750 sh	—	—	3,750
2017-05-24	ELDNEledon Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+52.5K sh	—	—	52,500
2017-05-10	ELDNEledon Pharmaceuticals, Inc.P Purchase	See Remarks	PPurchase	+10K sh	$9.99	+$100K	21,590
2014-12-18	AVANIR PHARMACEUTICALS, INC.S Sale	Vice President, Finance	SSale	−5,780 sh	$16.93	−$97.9K	108,797
2014-12-16	AVANIR PHARMACEUTICALS, INC.M Exercise/Conversion	Vice President, Finance	MExercise/Conversion	+12.5K sh	$2.59	+$32.4K	127,077
2014-12-16	AVANIR PHARMACEUTICALS, INC.M Exercise/Conversion	Vice President, Finance	MExercise/Conversion	+17.5K sh	$4.18	+$73.2K	144,577
2014-12-16	AVANIR PHARMACEUTICALS, INC.S Sale	Vice President, Finance	SSale	−12.5K sh	$16.94	−$212K	132,077
2014-12-16	AVANIR PHARMACEUTICALS, INC.S Sale	Vice President, Finance	SSale	−17.5K sh	$16.94	−$296K	114,577
2014-12-16	AVANIR PHARMACEUTICALS, INC.Stock Option (Right to Buy)M Exercise/Conversion	Vice President, Finance	MExercise/Conversion	−12.5K sh	—	—	17,500
2014-12-16	AVANIR PHARMACEUTICALS, INC.Stock Option (Right to Buy)M Exercise/Conversion	Vice President, Finance	MExercise/Conversion	−17.5K sh	—	—	0
2014-11-10	AVANIR PHARMACEUTICALS, INC.A Award	Vice President, Finance	AAward	+32K sh	—	—	94,733
2014-11-10	AVANIR PHARMACEUTICALS, INC.A Award	Vice President, Finance	AAward	+19.8K sh	—	—	114,577
2014-10-24	AVANIR PHARMACEUTICALS, INC.S Sale	Vice President, Finance	SSale	−2,080 sh	$11.81	−$24.6K	77,791
2014-09-15	AVANIR PHARMACEUTICALS, INC.S Sale	Vice President, Finance	SSale	−55K sh	$9.45	−$520K	79,871
2014-09-15	AVANIR PHARMACEUTICALS, INC.Stock Option (right to Buy)M Exercise/Conversion	Vice President, Finance	MExercise/Conversion	−55K sh	—	—	17,500
2014-08-26	AVANIR PHARMACEUTICALS, INC.S Sale	Vice President, Finance	SSale	−2,110 sh	$6.10	−$12.9K	79,871
2014-02-12	AVANIR PHARMACEUTICALS, INC.A Award	Vice President, Finance	AAward	+29.3K sh	—	—	92,527
2014-02-12	AVANIR PHARMACEUTICALS, INC.A Award	Vice President, Finance	AAward	+15.1K sh	—	—	107,577
2013-12-18	AVANIR PHARMACEUTICALS, INC.S Sale	Vice President, Finance	SSale	−2,450 sh	$2.63	−$6,445.46	63,202
2013-12-13	AVANIR PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Vice President, Finance	AAward	+17.3K sh	—	—	17,250
2013-05-15	AVANIR PHARMACEUTICALS, INC.S Sale	Vice President, Finance	SSale	−20K sh	$3.29	−$65.8K	65,652
2013-05-15	AVANIR PHARMACEUTICALS, INC.M Exercise/Conversion	Vice President, Finance	MExercise/Conversion	+4,000 sh	$0.88	+$3,520	69,652
2013-05-15	AVANIR PHARMACEUTICALS, INC.M Exercise/Conversion	Vice President, Finance	MExercise/Conversion	+15K sh	$0.88	+$13.2K	84,652
2013-05-15	AVANIR PHARMACEUTICALS, INC.M Exercise/Conversion	Vice President, Finance	MExercise/Conversion	+38.7K sh	$0.88	+$34.1K	123,352
2013-05-15	AVANIR PHARMACEUTICALS, INC.S Sale	Vice President, Finance	SSale	−57.7K sh	$3.28	−$189K	65,652
2013-05-15	AVANIR PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Vice President, Finance	MExercise/Conversion	+4,000 sh	—	—	0
2013-05-15	AVANIR PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Vice President, Finance	MExercise/Conversion	+15K sh	—	—	0
2013-05-15	AVANIR PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Vice President, Finance	MExercise/Conversion	+38.7K sh	—	—	0
2012-12-17	AVANIR PHARMACEUTICALS, INC.A Award	Vice President, Finance	AAward	+21.3K sh	—	—	76,689
2012-12-17	AVANIR PHARMACEUTICALS, INC.A Award	Vice President, Finance	AAward	+8,963 sh	—	—	85,652
2012-12-17	AVANIR PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Vice President, Finance	AAward	+32.5K sh	—	—	32,500
2012-12-03	AVANIR PHARMACEUTICALS, INC.S Sale	Vice President, Finance	SSale	−2,845 sh	$2.55	−$7,257.595	55,401
2012-09-17	AVANIR PHARMACEUTICALS, INC.M Exercise/Conversion	Vice President, Finance	MExercise/Conversion	+65K sh	$0.53	+$34.5K	123,246
2012-09-17	AVANIR PHARMACEUTICALS, INC.S Sale	Vice President, Finance	SSale	−65K sh	$3.49	−$227K	58,246
2012-09-17	AVANIR PHARMACEUTICALS, INC.Employee Stock Option (right to buy)M Exercise/Conversion	Vice President, Finance	MExercise/Conversion	−65K sh	—	—	65,000
2012-03-06	AVANIR PHARMACEUTICALS, INC.P Purchase	Vice President, Finance	PPurchase	+3,000 sh	$2.60	+$7,794.9	3,000
2011-12-15	AVANIR PHARMACEUTICALS, INC.A Award	Vice President, Finance	AAward	+6,250 sh	—	—	44,496
2011-12-15	AVANIR PHARMACEUTICALS, INC.A Award	Vice President, Finance	AAward	+13.8K sh	—	—	58,246
2011-12-15	AVANIR PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Vice President, Finance	AAward	+90K sh	—	—	90,000
2011-12-02	AVANIR PHARMACEUTICALS, INC.S Sale	Vice President, Finance	SSale	−2,676 sh	$2.38	−$6,371.824	38,246
2011-11-11	AVANIR PHARMACEUTICALS, INC.M Exercise/Conversion	Vice President, Finance	MExercise/Conversion	+3,750 sh	$1.20	+$4,500	44,672
2011-11-11	AVANIR PHARMACEUTICALS, INC.M Exercise/Conversion	Vice President, Finance	MExercise/Conversion	+12K sh	$0.88	+$10.6K	56,672

Recent filings

Accepted (ET)
Mar 314
OCAMPO CHRISTINE0000899243-21-014102
SEC(opens sec.gov)
May 44
OCAMPO CHRISTINE0001209191-20-026839
SEC(opens sec.gov)
Jan 94
OCAMPO CHRISTINE0000899243-20-000882
SEC(opens sec.gov)
Jan 84
OCAMPO CHRISTINE0000899243-19-000776
SEC(opens sec.gov)
Oct 174
OCAMPO CHRISTINE0001209191-18-055410
SEC(opens sec.gov)
May 264
Novus Therapeutics, Inc.0000899243-17-014539
SEC(opens sec.gov)
May 114
Novus Therapeutics, Inc.0000899243-17-012930
SEC(opens sec.gov)
Dec 184
AVANIR PHARMACEUTICALS, INC.0001209191-14-076841
SEC(opens sec.gov)
Nov 124
AVANIR PHARMACEUTICALS, INC.0001209191-14-068330
SEC(opens sec.gov)

Companies

Address

101 ENTERPRISE, SUITE 300

ALISO VIEJO, CA, 92656